Eric D Vidoni1, Jill K Morris1, Amber Watts2, Mark Perry3, Jon Clutton1, Angela Van Sciver1, Ashwini S Kamat1, Jonathan Mahnken1,4, Suzanne L Hunt1,4, Ryan Townley1, Robyn Honea1, Ashley R Shaw1, David K Johnson5, James Vacek6, Jeffrey M Burns1. 1. University of Kansas Alzheimer's Disease Center, Fairway, KS, United States of America. 2. Department of Psychology, University of Kansas, Lawrence, KS, United States of America. 3. Department of Radiology, University of Kansas Health System, Kansas City, KS, United States of America. 4. Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, United States of America. 5. Department of Neurology, University of California-Davis, Sacramento, CA, United States of America. 6. Department of Cardiovascular Medicine, University of Kansas Health System, Kansas City, KS, United States of America.
Abstract
BACKGROUND: Our goal was to investigate the role of physical exercise to protect brain health as we age, including the potential to mitigate Alzheimer's-related pathology. We assessed the effect of 52 weeks of a supervised aerobic exercise program on amyloid accumulation, cognitive performance, and brain volume in cognitively normal older adults with elevated and sub-threshold levels of cerebral amyloid as measured by amyloid PET imaging. METHODS AND FINDINGS: This 52-week randomized controlled trial compared the effects of 150 minutes per week of aerobic exercise vs. education control intervention. A total of 117 underactive older adults (mean age 72.9 [7.7]) without evidence of cognitive impairment, with elevated (n = 79) or subthreshold (n = 38) levels of cerebral amyloid were randomized, and 110 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. We conducted 18F-AV45 PET imaging of cerebral amyloid and anatomical MRI for whole brain and hippocampal volume at baseline and Week 52 follow-up to index brain health. Neuropsychological tests were conducted at baseline, Week 26, and Week 52 to assess executive function, verbal memory, and visuospatial cognitive domains. Cardiorespiratory fitness testing was performed at baseline and Week 52 to assess response to exercise. The aerobic exercise group significantly improved cardiorespiratory fitness (11% vs. 1% in the control group) but there were no differences in change measures of amyloid, brain volume, or cognitive performance compared to control. CONCLUSIONS: Aerobic exercise was not associated with reduced amyloid accumulation in cognitively normal older adults with cerebral amyloid. In spite of strong systemic cardiorespiratory effects of the intervention, the observed lack of cognitive or brain structure benefits suggests brain benefits of exercise reported in other studies are likely to be related to non-amyloid effects. TRIAL REGISTRATION: NCT02000583; ClinicalTrials.gov.
BACKGROUND: Our goal was to investigate the role of physical exercise to protect brain health as we age, including the potential to mitigate Alzheimer's-related pathology. We assessed the effect of 52 weeks of a supervised aerobic exercise program on amyloid accumulation, cognitive performance, and brain volume in cognitively normal older adults with elevated and sub-threshold levels of cerebral amyloid as measured by amyloid PET imaging. METHODS AND FINDINGS: This 52-week randomized controlled trial compared the effects of 150 minutes per week of aerobic exercise vs. education control intervention. A total of 117 underactive older adults (mean age 72.9 [7.7]) without evidence of cognitive impairment, with elevated (n = 79) or subthreshold (n = 38) levels of cerebral amyloid were randomized, and 110 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. We conducted 18F-AV45 PET imaging of cerebral amyloid and anatomical MRI for whole brain and hippocampal volume at baseline and Week 52 follow-up to index brain health. Neuropsychological tests were conducted at baseline, Week 26, and Week 52 to assess executive function, verbal memory, and visuospatial cognitive domains. Cardiorespiratory fitness testing was performed at baseline and Week 52 to assess response to exercise. The aerobic exercise group significantly improved cardiorespiratory fitness (11% vs. 1% in the control group) but there were no differences in change measures of amyloid, brain volume, or cognitive performance compared to control. CONCLUSIONS: Aerobic exercise was not associated with reduced amyloid accumulation in cognitively normal older adults with cerebral amyloid. In spite of strong systemic cardiorespiratory effects of the intervention, the observed lack of cognitive or brain structure benefits suggests brain benefits of exercise reported in other studies are likely to be related to non-amyloid effects. TRIAL REGISTRATION: NCT02000583; ClinicalTrials.gov.
Authors: Kirk I Erickson; Michelle W Voss; Ruchika Shaurya Prakash; Chandramallika Basak; Amanda Szabo; Laura Chaddock; Jennifer S Kim; Susie Heo; Heloisa Alves; Siobhan M White; Thomas R Wojcicki; Emily Mailey; Victoria J Vieira; Stephen A Martin; Brandt D Pence; Jeffrey A Woods; Edward McAuley; Arthur F Kramer Journal: Proc Natl Acad Sci U S A Date: 2011-01-31 Impact factor: 11.205
Authors: Jaime Perales-Puchalt; Ashley Shaw; Jerrihlyn L McGee; W Todd Moore; Ladson Hinton; Jason Resendez; Stephanie Monroe; John Dwyer; Eric D Vidoni Journal: Hisp Health Care Int Date: 2019-12-15
Authors: P S Aisen; S Andrieu; C Sampaio; M Carrillo; Z S Khachaturian; B Dubois; H H Feldman; R C Petersen; E Siemers; R S Doody; S B Hendrix; M Grundman; L S Schneider; R J Schindler; E Salmon; W Z Potter; R G Thomas; D Salmon; M Donohue; M M Bednar; J Touchon; B Vellas Journal: Neurology Date: 2010-12-22 Impact factor: 9.910
Authors: Christopher M Clark; Michael J Pontecorvo; Thomas G Beach; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Anupa Arora; Alan P Carpenter; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Daniel M Skovronsky Journal: Lancet Neurol Date: 2012-06-28 Impact factor: 44.182
Authors: Anna Rosenberg; Tiia Ngandu; Minna Rusanen; Riitta Antikainen; Lars Bäckman; Satu Havulinna; Tuomo Hänninen; Tiina Laatikainen; Jenni Lehtisalo; Esko Levälahti; Jaana Lindström; Teemu Paajanen; Markku Peltonen; Hilkka Soininen; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Alina Solomon; Miia Kivipelto Journal: Alzheimers Dement Date: 2017-10-19 Impact factor: 21.566
Authors: Lena L Law; Rachael N Rol; Stephanie A Schultz; Ryan J Dougherty; Dorothy F Edwards; Rebecca L Koscik; Catherine L Gallagher; Cynthia M Carlsson; Barbara B Bendlin; Henrik Zetterberg; Kaj Blennow; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson; Dane B Cook; Ozioma C Okonkwo Journal: Alzheimers Dement (Amst) Date: 2018-02-06
Authors: Christopher G Schwarz; Jeffrey L Gunter; Val J Lowe; Stephen Weigand; Prashanthi Vemuri; Matthew L Senjem; Ronald C Petersen; David S Knopman; Clifford R Jack Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Eric D Vidoni; Amanda Szabo-Reed; Chaeryon Kang; Ashley R Shaw; Jaime Perales-Puchalt; George Grove; Morgan Hamill; Donovan Henry; Jeffrey M Burns; Charles Hillman; Arthur F Kramer; Edward McAuley; Kirk I Erickson Journal: Contemp Clin Trials Commun Date: 2020-10-09
Authors: Ryan J Dougherty; Janani Ramachandran; Fangyu Liu; Yang An; Amal A Wanigatunga; Qu Tian; Murat Bilgel; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick; Jennifer A Schrack Journal: Alzheimers Dement (Amst) Date: 2021-08-20
Authors: Carolyn S Kaufman; Robyn A Honea; Joseph Pleen; Rebecca J Lepping; Amber Watts; Jill K Morris; Sandra A Billinger; Jeffrey M Burns; Eric D Vidoni Journal: J Cereb Blood Flow Metab Date: 2021-01-28 Impact factor: 6.200
Authors: Zachary D Green; Casey S John; Paul J Kueck; Jeffrey M Burns; Mark Perry; Joseph Donald; Jonathan D Mahnken; Robyn A Honea; Eric D Vidoni; Jill K Morris Journal: Contemp Clin Trials Date: 2021-05-27 Impact factor: 2.226
Authors: Bo Kyung Sohn; Min Soo Byun; Dahyun Yi; So Yeon Jeon; Jun Ho Lee; Young Min Choe; Dong Woo Lee; Jun-Young Lee; Yu Kyeong Kim; Chul-Ho Sohn; Dong Young Lee Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Matthew K Taylor; Debra K Sullivan; Jill K Morris; Eric D Vidoni; Robyn A Honea; Jonathan D Mahnken; Jeffrey M Burns Journal: Front Nutr Date: 2021-09-27
Authors: Robyn A Honea; Casey S John; Zachary D Green; Paul J Kueck; Matthew K Taylor; Rebecca J Lepping; Ryan Townley; Eric D Vidoni; Jeffery M Burns; Jill K Morris Journal: Alzheimers Dement (N Y) Date: 2022-02-01
Authors: Bernadette A Fausto; Solaleh Azimipour; Lisa Charles; Christina Yarborough; Keyla Grullon; Emily Hokett; Paul R Duberstein; Mark A Gluck Journal: J Appl Gerontol Date: 2021-05-03